Metraipolis › archive › dc_e6fbc667fb5c
Formulation considerations in enhancing olfactory mucosal deposition for nose-to-brain drug delivery — Europe PMC PMID:41865231
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41865231
- DOI
- 10.1007/s13346-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T03:25:08.807Z
- SHA-256 of the archived text
30a4c010799fe30a2f0df7d3a06da5aa8d220cbfaad5ef96e01c71348e4c22b0- Stable URL of this page
https://metraipolis.com/documento/dc_e6fbc667fb5c
How to cite
Formulation considerations in enhancing olfactory mucosal deposition for nose-to-brain drug delivery — Europe PMC PMID:41865231 — Europe PMC (en), https://europepmc.org/article/MED/41865231 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e6fbc667fb5c (Metraipolis archive dc_e6fbc667fb5c, sha256 30a4c010799fe30a2f0df7d3a06da5aa8d220cbfaad5ef96e01c71348e4c22b0)
BibTeX
@misc{dce6fbc667fb5c,
title = {Formulation considerations in enhancing olfactory mucosal deposition for nose-to-brain drug delivery — Europe PMC PMID:41865231},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41865231},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e6fbc667fb5c; sha256 30a4c010799fe30a2f0df7d3a06da5aa8d220cbfaad5ef96e01c71348e4c22b0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41865231. Agents can read the archived copy with the MCP tool read_document.